Viewing Study NCT07132502


Ignite Creation Date: 2025-12-25 @ 4:05 AM
Ignite Modification Date: 2025-12-31 @ 2:06 PM
Study NCT ID: NCT07132502
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-08-20
First Post: 2025-07-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment Intermittent Periods Based on ctDNA-MRD(Circulating Tumor DNA-minimal Residual Disease) Status in Advanced HER2-Positive Breast Cancer
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module